Cipla (CIPLA)
NSE
- Open
- N/A
- High
- N/A
- Low
- N/A
- Volume
- N/A
- Market cap
- ₹1.13T
Cipla (CIPLA) last traded at ₹1,404.10, up 0.15% on NSE as of 5 Nov 2026, 15:28 GMT+0530.
Cipla forecasts and price
Scroll here to load data.
Key statistics
Cipla stock research: financials and ownership
Cipla revenue, operating income and net income
Scroll here to load data.
Key financial metrics
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 3.24M |
| Shares Outstanding | 807.00M |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Cipla revenue by segment
Scroll here to load data.
Cipla revenue by region
Scroll here to load data.
Cipla stock margins
Scroll here to load data.
Cipla historical valuation
Scroll here to load data.
Cipla annual returns
Scroll here to load data.
Cipla financial statements
Income statement, balance sheet and cash flow, with annual and quarterly periods.
Scroll here to load statements.
Related Articles & Updates
TechGraph News · 2026-10-18The Connected Exchange: NCDEX CTO Balkrishna Shankwalker on the Future of the Commodity Market
TechGraph News · 2026-10-15NumanCap Review 2026 | Markets, Margin and Mobile
TechGraph News · 2026-10-01What Does India’s First Tokenised Bond Pilot Mean for the Debt Market?
TechGraph News · 2026-09-15Javier Olivan Plans $1.04 Million Meta Share Sale
TechGraph News · 2026-09-13NVIDIA Awards 172,507 Shares to EVP Nicholas Parker
TechGraph News · 2026-09-13Meta CPO Chris Cox Sells Shares Worth $13 Mn
Cipla fair value
Discounted cash flow fair value compared with the market price.
Scroll here to load data.
Cipla company rating
Composite rating and the factor scores behind it.
Scroll here to load data.
Cipla financial ratios
Trailing twelve month ratios.
Scroll here to load data.
Cipla financial scores
Altman Z-score, Piotroski score and related health scores.
Scroll here to load data.
Cipla one-year risk
One-year return, volatility, Sharpe ratio and max drawdown.
Scroll here to load data.
Cipla peers
Related companies.
Scroll here to load data.
Cipla earnings calls
Transcripts listed for this ticker.
Scroll here to load data.
People also watch
Trending global stocks
Related in Pharmaceuticals
About Cipla
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.
Founded byKhwaja Abdul Hamied
Company profile
Cipla executives and management
Cipla — frequently asked questions
What is the Cipla share price today?
Cipla (CIPLA) last traded at ₹1,404.10, up 0.15% on NSE as of 5 Nov 2026, 15:28 GMT+0530.
Where is Cipla listed?
Cipla trades as CIPLA on NSE.
Price quotes refresh periodically while this page stays open; the chart follows the quote and refreshes exchange history less often. Some venues delay data by 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.